News & Events

Latest News

28 February 2017Immunocore to Present at the Cowen and Company 37th Annual Healthcare Conference

01 December 2016Immunocore wins Financing Deal of the Year at the 12th Annual SCRIP Awards 2016

09 November 2016Immunocore Presents Positive Monotherapy Data in Uveal Melanoma at the Society for Melanoma Research (SMR) 2016 Congress

12 October 2016Immunocore Appoints Paul Fry as Chief Financial Officer

12 September 2016Immunocore Ranked in the Sunday Times Hiscox Tech Track 100

07 September 2016Immunocore Wins Private UK Life Science Company of the Year at Biotech and Money Assembly and Awards.

08 June 2016Immunocore’s ImmTAV shown to redirect the immune system to kill HIV-infected cells from patients treated with antiretroviral therapy

06 June 2016Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting

30 March 2016Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma

25 January 2016Immunocore’s IMCgp100 Granted Orphan Drug Designation by US FDA for the Treatment of Uveal Melanoma

←
1
2
3
4
5
6
7
→

News archive